Genworth Financial (GNW) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 22, 2025, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals by specified deadlines.
Voting matters and shareholder proposals
Election of ten directors, with all nominees recommended by the board.
Advisory vote on named executive officer compensation (say-on-pay) recommended for approval.
Approval of the 2025 Omnibus Incentive Plan proposed and recommended.
Ratification of KPMG LLP as independent registered public accounting firm for 2025.
Amendment to remove "Pass-Through Voting" provision from Genworth Holdings, Inc. Certificate of Incorporation.
Board of directors and corporate governance
Ten director nominees listed, including G. Kent Conrad, Karen E. Dyson, and others, all recommended for election.
Board's recommendations provided for all voting items, using the WHITE proxy card.
Latest events from Genworth Financial
- Proxy details 2025 performance, capital returns, and key votes on directors, pay, and auditor.GNW
Proxy filing24 Mar 2026 - Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Strong 2024 results, expanded aging care, and key governance proposals drive shareholder value.GNW
Proxy Filing1 Dec 2025 - Q2 2025 net income was $51M, with $94M in capital returns and CareScout network expansion.GNW
Q2 202516 Nov 2025